UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Is the clinical benefit of primary prevention implantable cardioverter-defibrillator overestimated? The role of sudden cardiac death to total mortality ratio

European heart journal, 2020-12, Vol.41 (47), p.4525-4526

2020

Link zum Volltext

Verfügbarkeit prüfen

Declining clinical benefit of ICD in heart failure patients: Temporal trend of mortality outcomes from randomized controlled trials

Journal of cardiology, 2020-02, Vol.75 (2), p.148-154

2020

Link zum Volltext

Verfügbarkeit prüfen

Acute Atrial Dilatation Slows Conduction and Increases AF Vulnerability in the Human Atrium

Journal of cardiovascular electrophysiology, 2011-04, Vol.22 (4), p.394-401

2011

Link zum Volltext

Verfügbarkeit prüfen

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation

BMC cardiovascular disorders, 2021-11, Vol.21 (1), p.553-553, Article 553

2021

Link zum Volltext

Verfügbarkeit prüfen

Author’s reply: “Declining clinical benefit of ICD in heart failure patients”

Journal of cardiology, 2020-05, Vol.75 (5), p.584-585

2020

Link zum Volltext

Verfügbarkeit prüfen

Nodal recovery, dual pathway physiology, and concealed conduction determine complex AV dynamics in human atrial tachyarrhythmias

American journal of physiology. Heart and circulatory physiology, 2012-11, Vol.303 (10), p.H1219-H1228

2012

Link zum Volltext

Verfügbarkeit prüfen

Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients

Frontiers in physiology, 2017-10, Vol.8, p.873-873

2017

Link zum Volltext

Verfügbarkeit prüfen

Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction

JACC. Cardiovascular imaging, , Vol.9 (9), p.1046-1055

Link zum Volltext

Verfügbarkeit prüfen

Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals

Europace (London, England), 2006-08, Vol.8 (8), p.644-650

2006

Link zum Volltext

Verfügbarkeit prüfen

Ventricular tachycardia-inducibility predicts arrhythmic events in post-myocardial infarction patients with low ejection fraction. A systematic review and meta-analysis

International journal of cardiology. Heart & vasculature, 2018-09, Vol.20, p.7-13

2018

Link zum Volltext

Verfügbarkeit prüfen

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial

BMC cardiovascular disorders, 2013-04, Vol.13 (1), p.28-28, Article 28

2013

Link zum Volltext

Verfügbarkeit prüfen

Myocardial fibrosis predicts ventricular tachyarrhythmias

Trends in cardiovascular medicine, 2017-07, Vol.27 (5), p.363-372

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary Prevention of Sudden Arrhythmic Death in Dilated Cardiomyopathy

JACC. Heart failure, 2017, Vol.5 (1), p.39-43

2017

Link zum Volltext

Verfügbarkeit prüfen

Systematic Review and Meta-Analysis: Renin-Angiotensin System Inhibitors in the Prevention of Atrial Fibrillation Recurrences. An Unfulfilled Hope

Cardiovascular drugs and therapy, 2012-02, Vol.26 (1), p.47-54

2012

Link zum Volltext

Verfügbarkeit prüfen

Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis

JACC. Cardiovascular imaging, 2016-09, Vol.9 (9), p.1046-1055

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial

The American heart journal, 2011-08, Vol.162 (2), p.382-389

2011

Link zum Volltext

Verfügbarkeit prüfen

Anatomic Localization of Rapid Repetitive Sources in Persistent Atrial Fibrillation

JACC. Cardiovascular imaging, 2012-12, Vol.5 (12), p.1211-1220

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial

The American heart journal, 2010-05, Vol.159 (5), p.857-863

2010

Link zum Volltext

Verfügbarkeit prüfen

Primary Prevention of Sudden Arrhythmic Death in Dilated Cardiomyopathy: Current Guidelines and Risk Stratification

JACC. Heart failure, 2017-01, Vol.5 (1), p.39-43

2017

Link zum Volltext

Verfügbarkeit prüfen

Heart Rate Turbulence Is a Powerful Predictor of Cardiac Death and Ventricular Arrhythmias in Postmyocardial Infarction and Heart Failure Patients: A Systematic Review and Meta-Analysis

Circulation. Arrhythmia and electrophysiology, 2016-12, Vol.9 (12), p.e004610-e004610

2016

Link zum Volltext

Verfügbarkeit prüfen

Characterization of rate and regularity of ventricular response during atrial tachyarrhythmias. Insight on atrial and nodal determinants

Physiological measurement, 2017-05, Vol.38 (5), p.800

2017

Link zum Volltext

Verfügbarkeit prüfen

Heart failure patients unresponsive to implantable cardioverter‐defibrillator therapy: a neglected problem

European journal of heart failure, 2019-12, Vol.21 (12), p.1507-1509

2019

Link zum Volltext

Verfügbarkeit prüfen

The logical operator map identifies novel candidate markers for critical sites in patients with atrial fibrillation

Progress in biophysics and molecular biology, 2014-08, Vol.115 (2-3), p.186-197

2014

Link zum Volltext

Verfügbarkeit prüfen

The post‐DANISH era in clinical cardiology: Need of a better selection of patients for implantable cardioverter‐defibrillator in dilated cardiomyopathy

Journal of cardiovascular electrophysiology, 2017-11, Vol.28 (11), p.E7-E7

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(57)
Science & Technology
(55)
Life Sciences & Biomedicine
(54)
Cardiac & Cardiovascular Systems
(46)
Cardiovascular System & Cardiology
(46)
Female
(30)
Male
(29)
Middle Aged
(29)
Aged
(25)
Biological And Medical Sciences
(18)
Heart
(17)
Atrial Fibrillation
(16)
Medical Sciences
(16)
Cardiology. Vascular System
(15)
Electrocardiography
(14)
Risk Factors
(13)
Treatment Outcome
(12)
Adult
(10)
Cardiology And Cardiovascular Medicine
(10)
Atrial Fibrillation - Diagnosis
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is the clinical benefit of primary prevention implantable cardioverter-defibrillator overestimated? The role of sudden cardiac death to total mortality ratio

Declining clinical benefit of ICD in heart failure patients: Temporal trend of mortality outcomes from randomized controlled trials

Acute Atrial Dilatation Slows Conduction and Increases AF Vulnerability in the Human Atrium

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation

Author’s reply: “Declining clinical benefit of ICD in heart failure patients”

Nodal recovery, dual pathway physiology, and concealed conduction determine complex AV dynamics in human atrial tachyarrhythmias

Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients

Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction

Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals

Ventricular tachycardia-inducibility predicts arrhythmic events in post-myocardial infarction patients with low ejection fraction. A systematic review and meta-analysis

Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial

Myocardial fibrosis predicts ventricular tachyarrhythmias

Primary Prevention of Sudden Arrhythmic Death in Dilated Cardiomyopathy

Systematic Review and Meta-Analysis: Renin-Angiotensin System Inhibitors in the Prevention of Atrial Fibrillation Recurrences. An Unfulfilled Hope

Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis

Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial

Anatomic Localization of Rapid Repetitive Sources in Persistent Atrial Fibrillation

Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial

Primary Prevention of Sudden Arrhythmic Death in Dilated Cardiomyopathy: Current Guidelines and Risk Stratification

Heart Rate Turbulence Is a Powerful Predictor of Cardiac Death and Ventricular Arrhythmias in Postmyocardial Infarction and Heart Failure Patients: A Systematic Review and Meta-Analysis

Characterization of rate and regularity of ventricular response during atrial tachyarrhythmias. Insight on atrial and nodal determinants

Heart failure patients unresponsive to implantable cardioverter‐defibrillator therapy: a neglected problem

The logical operator map identifies novel candidate markers for critical sites in patients with atrial fibrillation

The post‐DANISH era in clinical cardiology: Need of a better selection of patients for implantable cardioverter‐defibrillator in dilated cardiomyopathy

Suchergebnisse filtern